207 related articles for article (PubMed ID: 32024385)
1. Restrictive cardiac phenotype as primary cause of impaired aerobic capacity in Afro-Caribbean patients with val122ile variant transthyretin amyloid cardiomyopathy.
Monfort A; Banydeen R; Demoniere F; Courty B; Codiat R; Neviere R; Inamo J
Amyloid; 2020 Sep; 27(3):145-152. PubMed ID: 32024385
[No Abstract] [Full Text] [Related]
2. Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy.
Maestro-Benedicto A; Vela P; de Frutos F; Mora N; Pomares A; Gonzalez-Vioque E; Briceño A; Cabrera E; Cobo-Marcos M; Dominguez F; Gonzalez-Lopez E; Segovia J; Lara-Pezzi E; Garcia-Pavia P
Eur J Heart Fail; 2022 Dec; 24(12):2367-2373. PubMed ID: 35999650
[TBL] [Abstract][Full Text] [Related]
3. Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?
Razvi Y; Ioannou A; Patel RK; Chacko L; Karia N; Riefolo M; Porcari A; Rauf MU; Starr N; Ganesananthan S; Blakeney I; Kaza N; Filisetti S; Bolhuis RE; Rowczenio D; Gilbertson J; Hutt D; Mahmood S; Lachmann HJ; Wechalekar AD; Kotecha T; Knight DS; Coghlan JG; Petrie A; Whelan CJ; Venneri L; Martinez-Naharro A; Hawkins P; Fontana M; Gillmore JD
Eur J Heart Fail; 2024 Feb; 26(2):383-393. PubMed ID: 37953725
[TBL] [Abstract][Full Text] [Related]
4. Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS.
Caponetti AG; Rapezzi C; Gagliardi C; Milandri A; Dispenzieri A; Kristen AV; Wixner J; Maurer MS; Garcia-Pavia P; Tournev I; Planté-Bordeneuve V; Chapman D; Amass L;
JACC Heart Fail; 2021 Oct; 9(10):736-746. PubMed ID: 34391735
[TBL] [Abstract][Full Text] [Related]
5. Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).
Maurer MS; Hanna M; Grogan M; Dispenzieri A; Witteles R; Drachman B; Judge DP; Lenihan DJ; Gottlieb SS; Shah SJ; Steidley DE; Ventura H; Murali S; Silver MA; Jacoby D; Fedson S; Hummel SL; Kristen AV; Damy T; Planté-Bordeneuve V; Coelho T; Mundayat R; Suhr OB; Waddington Cruz M; Rapezzi C;
J Am Coll Cardiol; 2016 Jul; 68(2):161-72. PubMed ID: 27386769
[TBL] [Abstract][Full Text] [Related]
6. Cardiac sympathetic denervation in wild-type transthyretin amyloidosis.
Gimelli A; Aimo A; Vergaro G; Genovesi D; Santonato V; Kusch A; Emdin M; Marzullo P
Amyloid; 2020 Dec; 27(4):237-243. PubMed ID: 32441155
[TBL] [Abstract][Full Text] [Related]
7. Mutant Thr95Ile Transthyretin-Related Cardiac Amyloidosis With Polyneuropathy.
Kim K; Oh J; Lee ST; Shim HS; Kang SM
Circ J; 2019 Oct; 83(11):2328. PubMed ID: 31243187
[No Abstract] [Full Text] [Related]
8. Afro-Caribbean Heart Failure in the United Kingdom: Cause, Outcomes, and ATTR V122I Cardiac Amyloidosis.
Dungu JN; Papadopoulou SA; Wykes K; Mahmood I; Marshall J; Valencia O; Fontana M; Whelan CJ; Gillmore JD; Hawkins PN; Anderson LJ
Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27618855
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT.
Rapezzi C; Elliott P; Damy T; Nativi-Nicolau J; Berk JL; Velazquez EJ; Boman K; Gundapaneni B; Patterson TA; Schwartz JH; Sultan MB; Maurer MS
JACC Heart Fail; 2021 Feb; 9(2):115-123. PubMed ID: 33309574
[TBL] [Abstract][Full Text] [Related]
10. Rare c.302C>T
Žebrauskienė D; Sadauskienė E; Masiulienė R; Aidietienė S; Šiaudinienė A; Pečeliūnas V; Žukauskaitė G; Žurauskas E; Valevičienė N; Barysienė J; Preikšaitienė E
Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399526
[No Abstract] [Full Text] [Related]
11. Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction.
Phan TT; Shivu GN; Abozguia K; Davies C; Nassimizadeh M; Jimenez D; Weaver R; Ahmed I; Frenneaux M
Circ Heart Fail; 2010 Jan; 3(1):29-34. PubMed ID: 19917649
[TBL] [Abstract][Full Text] [Related]
12. Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis.
Louwsma J; Brunger AF; Bijzet J; Kroesen BJ; Roeloffzen WWH; Bischof A; Kuhle J; Drost G; Lange F; Kuks JBM; Gans ROB; Hazenberg BPC; Nienhuis HLA
Amyloid; 2021 Mar; 28(1):50-55. PubMed ID: 32883119
[TBL] [Abstract][Full Text] [Related]
13. Transthyretin amyloid cardiomyopathy.
Garcia-Pavia P; Domínguez F; Gonzalez-Lopez E
Med Clin (Barc); 2021 Feb; 156(3):126-134. PubMed ID: 33138983
[TBL] [Abstract][Full Text] [Related]
14. Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis.
Kollmer J; Hegenbart U; Kimmich C; Hund E; Purrucker JC; Hayes JM; Lentz SI; Sam G; Jende JME; Schönland SO; Bendszus M; Heiland S; Weiler M
Ann Clin Transl Neurol; 2020 May; 7(5):799-807. PubMed ID: 32333729
[TBL] [Abstract][Full Text] [Related]
15. Amyloid Cardiomyopathy.
Bart NK; Thomas L; Korczyk D; Atherton JJ; Stewart GJ; Fatkin D
Heart Lung Circ; 2020 Apr; 29(4):575-583. PubMed ID: 32001152
[TBL] [Abstract][Full Text] [Related]
16. Variant Transthyretin Amyloidosis (ATTRv) in Hungary: First Data on Epidemiology and Clinical Features.
Pozsonyi Z; Peskó G; Takács H; Csuka D; Nagy V; Szilágyi Á; Hategan L; Muk B; Csányi B; Nyolczas N; Dézsi L; Molnár JM; Csillik A; Révész K; Iványi B; Szabó F; Birtalan K; Masszi T; Arányi Z; Sepp R
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440326
[TBL] [Abstract][Full Text] [Related]
17. Racial Differences in Val122Ile-Associated Transthyretin Cardiac Amyloidosis.
Batra J; Rosenblum H; Cappelli F; Zampieri M; Olivotto I; Griffin JM; Saith SE; Teruya S; De Los Santos J; Argiro A; Burkhoff D; Perfetto F; Maurer MS
J Card Fail; 2022 Jun; 28(6):950-959. PubMed ID: 34974181
[TBL] [Abstract][Full Text] [Related]
18. Phenotypes Associated With the Val122Ile, Leu58His, and Late-Onset Val30Met Variants in Patients With Hereditary Transthyretin Amyloidosis.
Zampino S; Sheikh FH; Vaishnav J; Judge D; Pan B; Daniel A; Brown E; Ebenezer G; Polydefkis M
Neurology; 2023 May; 100(19):e2036-e2044. PubMed ID: 36941075
[TBL] [Abstract][Full Text] [Related]
19. Heart Rate Reserve in Fontan Patients: Chronotropic Incompetence or Hemodynamic Limitation?
Claessen G; La Gerche A; Van De Bruaene A; Claeys M; Willems R; Dymarkowski S; Bogaert J; Claus P; Budts W; Heidbuchel H; Gewillig M
J Am Heart Assoc; 2019 May; 8(9):e012008. PubMed ID: 31041880
[TBL] [Abstract][Full Text] [Related]
20. Transthyretin Cardiac Amyloidosis in Black Americans.
Shah KB; Mankad AK; Castano A; Akinboboye OO; Duncan PB; Fergus IV; Maurer MS
Circ Heart Fail; 2016 Jun; 9(6):e002558. PubMed ID: 27188913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
